Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Investor Relations

In response to an e-mail I sent.

The ITC trial has concluded. Counsel for the MMP put forth a tremendous effort and we believe they did a fantastic job. We, like you, anxiously await the Court's ruling which is expected to be delieverd on Sept. 6th. Our successes will be promoted as they are achieved.

2
Jun 20, 2013 03:36PM
Share
New Message
Please login to post a reply